- Home
- Applications
- vaccinator
Refine by
Vaccinator Product Applications
34 applications found
Enable different strategies for vaccine development to attack rapidly mutating viruses such as influenza, HCV, HIV, or coronaviruses. Use our platform to assist in the creation and optimization of different types of vaccines such as virus-like particles (VLPs), DNA vaccines, RNA ...
ByTeselaGen Biotechnology, Inc. based in Portola Valley, CALIFORNIA (USA)
They can also be combined with bacteria or virus components to form archaeosomes or virosomes, respectively. These vaccines have been proved to be effective in inducing immune responses and providing a sustained exposure to the antigen. More than 30 clinical trials are currently using liposomes for vaccine delivery including HIV and several types of ...
ByNanovex Biotechnologies based in Llanera, SPAIN
The Nucleic Acid Vaccine Revolution is Just the Beginning. When they write the history of vaccines, this will probably be a turning point: Nucleic acid vaccines have shifted the immunology landscape with unrivaled speed and impact. While the world is focused on the rollout of COVID-19 vaccines, the race for the next generation of nucleic acid vaccines and therapeutics – targeted at a variety of other diseases – is on! ...
ByPharmaJet based in Golden, COLORADO (USA)
Inactivated polio vaccine (IPV) delivered intradermally with Tropis® can save money, improve beneficiary experience, achieve higher efficacy, and increase vaccine ...
ByPharmaJet based in Golden, COLORADO (USA)
Because the BacVax method is based on genomic and structural vaccinology, any bacteria can be analyzed for targets. Our vaccines will be able to address bacterial infections that currently have no vaccine options available, and we are ready to fill that ...
ByBacVax, Inc. based in Phoenix, ARIZONA (USA)
Premium
The pharmaceutical industry includes discovering, developing, producing, and marketing drugs to be used as medications and vaccines to treat and cure patients across the globe. The modern pharmaceutical industry began in the early 1800s and continues to grow rapidly until this day. ...
ByGalaxy Scientific Inc based in Nashua, NEW HAMPSHIRE (USA)
Our collective health depends on finding new vaccines and treatments for diseases and illnesses. Clinical trials are pivotal in getting medicines approved to help people in need. ...
ByModerna, Inc. based in Cambridge, MASSACHUSETTS (USA)
The first vaccine in the US labeled for needle-free delivery. Afluria® and Afluria QIV Influenza Vaccines are FDA Approved for use with the PharmaJet Stratis® Jet Injector Needle-free System. The Stratis Needle-free Injector is the first needle-free jet injector that is FDA approved for delivery of an influenza vaccine. A comprehensive clinical trial demonstrated that needle-free flu vaccine delivery with Afluria® is comparable to ...
ByPharmaJet based in Golden, COLORADO (USA)
Immune repertoire analysis has taken a predominant role in the development of vaccination strategies against infectious disease and has enabled characterization of the immune response against pathogens at high ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
Unlike conventional vaccination strategies, cancer vaccines are designed to mount responses against tumor-specific antigens, arising from somatic mutations specific to the cancer genome. ...
ByEnpicom B.V. based in s-Hertogenbosch, NETHERLANDS
Vaccine manufacturing has been widely popular ever since Pasteur developed the rabies vaccine in 1885. Since then vaccine manufacturing has continued to be popular due to the defense that vaccines provide against certain viruses. The human immune system is constantly defending itself against a barrage of viruses and we simply lack the capacity to recognize and fight against these ever changing pathogens. Vaccines are designed to ...
ByLonza Group Ltd based in Basel, SWITZERLAND
Current viral titer assay methods, a crucial component of vaccine & CGT development and production efforts, are generally slow, labor intensive, subjective, and difficult to standardize, often resulting in large errors or failures during critical production ...
ByLumaCyte, Inc. based in Charlottesville, VIRGINIA (USA)
As the COVID-19 pandemic continues, the SARS-CoV-2 virus is likely to become endemic with emerging novel variants, some of them seasonal. Updates to the various vaccines will be required, as will a range of anti-virals with a variety of mechanisms of action, for use in early infection and in hospitalizated patients, much like oseltamivir (Tamiflu) is used in certain populations for seasonal ...
ByCyrus Biotechnology Inc. based in Seattle, WASHINGTON (USA)
2A Pharma’s vaccine platform is based on mutated parvoviral particles consisting essentially of one protein. ...
By2A Pharma ApS based in Aalborg Øst, DENMARK
We are proud of the advancements we’ve made in pioneering new mRNA vaccines and treatments that may have the potential to treat and prevent rare ...
ByModerna, Inc. based in Cambridge, MASSACHUSETTS (USA)
The manufacture of biopharmaceutical agents such as therapeutic monoclonal antibodies, vaccines and cell-based therapies like CAR-T cells require the highest quality control against the contamination of adventitious agents. ...
ByAccuGenomics, Inc. based in Wilmington, NORTH CAROLINA (USA)
When you’re developing the next generation of small molecule therapeutics, biologics, or vaccines, getting reliable data is critical for success. So is speed. With products and services that can boost productivity, support regulatory compliance, and shorten time-to-market while ensuring high-quality assay results, Artel is helping BioPharma teams get ahead and stay ...
ByArtel, Inc. by Advanced Instruments based in Westbrook, MAINE (USA)
At the end of 2019, a novel coronavirus was identified as the cause of a cluster of pneumonia cases in Wuhan, a city in the Hubei Province of China. The severity and rapid spread of COVID-19 (caused by SARS-CoV-2), resulted in a global pandemic declared by the World Health Organization in March 2020. The virus has spread to more than 100 countries, including the United ...
ByNovavax based in Gaithersburg, MARYLAND (USA)
The application of DNA-based therapy mainly includes DNA-encoded compound library for new drugs research, genetically engineered bacterias drugs, nuelic acid vaccines, recombinant antibodies, small nucleic acid drugs, and gene editing. ...
ByCD Biosciences - htDNA-chip® based in Shirley, NEW YORK (USA)
Laser Force Cytology™ (LFC), rapid viral infectivity assay data correlates tightly with traditional plaque and TCID50 assays. Radiance® provides new information around host response and the viral life cycle, enabling a better understanding of cellular infection through the measurement of novel phenotypic ...
ByLumaCyte, Inc. based in Charlottesville, VIRGINIA (USA)